Early antithrombotic prophylaxis with low molecular weight heparin in neurosurgery
✍ Scribed by A. Kleindienst; H. B. Harvey; E. Mater; J. Bronst; J. Flack; K. Herenz; W. F. Haupt; R. Schön
- Publisher
- Springer Vienna
- Year
- 2003
- Tongue
- English
- Weight
- 265 KB
- Volume
- 145
- Category
- Article
- ISSN
- 0001-6268
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Administration of low‐molecular‐weight heparin (LMWH) and standard heparin was studied by evaluating vessel bleeding, patency, and thrombotic material following severe vascular trauma. Arteriotomy and intimectomy or venotomy and intimectomy were performed on small rabbit arteries or vei
Abstract In a prospective, double-blind controlled study we have compared the prophylactic efficacy against deep vein thrombosis of low-dose heparin + dihydroergotamine (A), low molecular weight heparin + dihydro-ergotamine (B) and placebo (C). A total of three hundred and fifty-six patients undergo
## Abstract We treated three thrombophilia‐complicated pregnant women (two antiphospholipid antibody syndrome, one protein C deficiency) with low molecular weight heparin (dalteparin). All three pregnancies including one twin pregnancy ended in live births without a decrease in bone mineral density